Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-026633
Filing Date
2025-03-21
Accepted
2025-03-21 16:01:53
Documents
4
Effectiveness Date
2025-03-21

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm259903d1_s8.htm S-8 56639
2 EXHIBIT 5.1 tm259903d1_ex5-1.htm EX-5.1 11151
3 EXHIBIT 23.2 tm259903d1_ex23-2.htm EX-23.2 2366
4 EX-FILING FEES tm259903d1_ex-filingfees.htm EX-FILING FEES 16795
  Complete submission text file 0001104659-25-026633.txt   87984
Mailing Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130
Business Address 12750 HIGH BLUFF DRIVE SUITE 475 SAN DIEGO CA 92130 858-246-6240
BELITE BIO, INC (Filer) CIK: 0001889109 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-286001 | Film No.: 25760393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)